A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-Resminostat

Clinical trial NCT04955340 · COMPLETED

Trial details

NCT number: NCT04955340
Sponsor: 4SC AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous T Cell Lymphoma Mycosis Fungoides Sezary Syndrome

Start date: 2021-10-12
Primary completion: 2022-01-19
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.